Wedbush Initiates Blueprint Medicines With Outperform By: Benzinga via Benzinga May 26, 2015 at 08:30 AM EDT Analysts at Wedbush initiated coverage on Blueprint Medicines Corp (NASDAQ: BPMC) with a Outperform rating. The target price for ... Read More >> Related Stocks: Blueprint Medicines Corp